Synergy CHC Corp. (SNYR)
1.46
-0.12
(-7.59%)
USD |
NASDAQ |
Feb 20, 16:00
1.46
0.00 (0.00%)
After-Hours: 17:47
Synergy CHC EPS Diluted (Quarterly) : 0.0124 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NeOnc Technologies Holdings, Inc. | -0.4485 |
| BioVie, Inc. | -0.7663 |
| NRX Pharmaceuticals, Inc. | -0.2649 |
| Acurx Pharmaceuticals, Inc. | -1.226 |
| Lantern Pharma, Inc. | -0.3856 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.1253M |
| Revenue (Quarterly) | 8.010M |
| Total Expenses (Quarterly) | 7.885M |
| Enterprise Value | 41.78M |
| Gross Profit Margin (Quarterly) | 70.50% |
| Profit Margin (Quarterly) | 1.56% |
| Earnings Yield | 20.00% |
| Operating Earnings Yield | 47.05% |
| Normalized Earnings Yield | 8.425 |